Incidence and Prediction of Immune Checkpoint Inhibitor-related Nephrotoxicity
2020 · Journal of Immunotherapy · 31 citations
https://doi.org/10.1097/cji.0000000000000338
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
41
Citations
3
h-index
1
i10-index
Roshni Radhakrishna is an academic researcher from Colorado Engineering (United States). The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Immunotherapy and Biomarkers & Pharmacological Effects and Toxicity Studies. The author has an h-index of 3, co-authored 6 publications.
Click to start Chat